PULM — Pulmatrix Income Statement
0.000.00%
Last trade - 00:00- $22.64m
- $13.12m
- $7.81m
- 41
- 23
- 85
- 48
Annual income statement for Pulmatrix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 12.6 | 5.17 | 6.07 | 7.3 | 7.81 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 22.5 | 25.3 | 25 | 22 | 17.6 |
| Operating Profit | -9.86 | -20.2 | -18.9 | -14.7 | -9.76 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -19.3 | -20.2 | -18.8 | -14.1 | -9.56 |
| Net Income After Taxes | -19.3 | -20.2 | -18.8 | -14.1 | -9.56 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -19.3 | -20.2 | -18.8 | -14.1 | -9.56 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -19.3 | -23.4 | -18.8 | -14.1 | -9.56 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -13.4 | -7.31 | -5.46 | -3.87 | -1.9 |